Laboratory monitoring should be guided by the patients clinical presentation and may include A1C, renal function, liver enzymes when indicated, electrolyte assessment for patients with significant gastrointestinal symptoms, and additional testing based on comorbid conditions
[1] Check your dose stage: record whether you are still titrating, on 1.7 mg, on 2.4 mg, or following a different prescriber-led plan
Healthcare practitioners can reinforce this practice at follow-up appointments and ask patients to demonstrate their skill
GLP-1 medications such as Wegovy and Ozempic were associated with a reduction in diagnoses of depression and anxiety in a new report
GLP-3 is what we call a triple-hormone receptor agonist
doi: 10.3390/biom11121749 99 HuanrongMJingjingWMinyuZJianhuaWZhenzhenWLiLet al